Organogenesis Holdings Inc.
ORGO
$2.48
$0.104.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.73% | 16.80% | 2.10% | -4.26% | 5.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.19% | 17.04% | 2.24% | -4.21% | 5.35% |
| Cost of Revenue | 21.33% | 14.34% | 5.51% | -2.02% | 2.02% |
| Gross Profit | 9.29% | 17.89% | 1.16% | -4.93% | 6.45% |
| SG&A Expenses | 6.73% | 10.60% | 6.88% | 7.16% | 10.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.79% | 9.14% | 4.68% | 2.19% | 7.76% |
| Operating Income | 221.94% | 186.11% | -88.49% | -205.03% | -64.35% |
| Income Before Tax | 117.65% | 1,773.32% | 58.24% | -65.17% | -327.10% |
| Income Tax Expenses | 118.66% | 370.94% | 3.57% | -480.07% | -272.05% |
| Earnings from Continuing Operations | 117.12% | 4,201.05% | 113.62% | 50.25% | -373.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 117.12% | 4,201.05% | 113.62% | 50.25% | -373.12% |
| EBIT | 221.94% | 186.11% | -88.49% | -205.03% | -64.35% |
| EBITDA | 81.55% | 107.98% | -31.95% | -89.45% | -24.84% |
| EPS Basic | 30.87% | 2,630.65% | -33.51% | 23.02% | -463.29% |
| Normalized Basic EPS | 349.28% | 229.73% | -65.73% | -221.90% | -65.44% |
| EPS Diluted | 22.95% | 844.86% | -34.98% | 21.07% | -574.79% |
| Normalized Diluted EPS | 288.21% | 215.53% | -74.84% | -225.41% | -66.78% |
| Average Basic Shares Outstanding | -2.43% | -3.75% | -3.45% | -2.14% | -0.81% |
| Average Diluted Shares Outstanding | -1.38% | -2.70% | -2.65% | -1.98% | -0.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |